Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2022-07-13 00:00:00 ET · period of report 2022-07-11 · accession 0001209191-22-042039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-13 | 2022-07-11 | VIR | Ramasastry Saira | Dir | A - Grant | $12.76 | +5,000 | 13.1K | +62% | +$63.8K |
| D | 2022-07-13 | 2022-07-11 | VIR | Ramasastry Saira | Dir | S - Sale | $30.00 | -5,000 | 8,092 | -38% | -$150.0K |
| D | 2022-07-13 | 2022-07-11 | VIR | Ramasastry Saira | Dir | M - OptEx | $0.00 | -5,000 | 42.8K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-11 | A | A | 5,000 | $12.76 | 13,092 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-11 | S | D | 5,000 | $30.00 | 8,092 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-07-11 | M | D | 5,000 | $0.00 | 42,777 | D | $12.76 · — to 2029-12-09 | 5,000 Common Stock | (F2) 1/3 of the shares subject to the stock option vested and became exercisable on September 4, 2020, and the remaining shares vest in 24 equal monthly installments thereafter. |